Your session is about to expire
← Back to Search
Suicidal Adolescent for Suicide
N/A
Recruiting
Led By David Sheridan, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four times daily up to one week
Awards & highlights
Summary
The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents.
Eligible Conditions
- Mental Health Issue
- Suicide
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ four times daily up to one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four times daily up to one week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Heart rate variability and Suicidality
Trial Design
1Treatment groups
Experimental Treatment
Group I: Suicidal AdolescentExperimental Treatment1 Intervention
he study will enroll subjects aged 13-17 years admitted with a chief complaint of acute suicidality or attempt. Patients will undergo physiologic and biometric monitoring in the hospital with a wrist-wearable device and chest wall ECG leads. They will undergo serial assessment four times daily to gather data regarding their activities, affect, and suicidality.
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
985 Previous Clinical Trials
7,385,580 Total Patients Enrolled
2 Trials studying Suicide
4,250 Patients Enrolled for Suicide
Analog Device, Inc.OTHER
13 Previous Clinical Trials
1,950 Total Patients Enrolled
David Sheridan, MDPrincipal InvestigatorOregon Health and Science University
3 Previous Clinical Trials
424 Total Patients Enrolled
1 Trials studying Suicide
250 Patients Enrolled for Suicide
Share this study with friends
Copy Link
Messenger